Skip to main content
. 2014 Jan 31;87(1035):20130626. doi: 10.1259/bjr.20130626

Figure 7.

Figure 7.

Pathways where radiation can synergize with immune adjuvant therapy for cancer. (1) Immunogenic cell death is promoted by ionizing radiation, through dendritic cell activation and, consequently, T-cell expansion. (2) Cytokines play a role in radiation therapy success. (3) NKG2D-ligands, sensitizing stressed cells to natural killer cells (innate immunity) are upregulated by radiation. (4) Chemokines can be induced by radiation, attracting effector T-cells to the tumour. (5) Radiation-induced interferon-gamma-dependent upregulation of cell adhesion molecule also influences antitumour immunity. (6) Heat shock proteins sensitize to cytotoxic granzymes. (7) Radiation can lead to enhanced expression of major histocompatibility complex (MCH)-I and to de novo expression of neoantigens. (8) Death receptors can be upregulated by irradiation. (9) CD8 T-cells are essential for the success of radiotherapy. Image courtesy of Norman Reppingen, Technical University of Darmstadt, Darmstadt, Germany. CTL, cytotoxic T cell; DC, dendritic cell; IFN, interferon; TCR, T cell receptor; TNF, tumour necrosis factor.